Stability of three cytotoxic drug infusions in the Graseby 9000 ambulatory infusion pump

Journal of Oncology Pharmacy Practice

Volumn 4, Issue 3, 1998, Pages 143-149

  Priston, Melanie J ^a   Sewell, Graham J ^a,b  

^a PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

^b NONE

Author keywords

Doxorubicin; etoposide; ifosfamide; mesna; stability; vincristine

Indexed keywords

EID: 84990386119     PISSN: 10781552     EISSN: None     Source Type: Journal    
DOI: 10.1177/107815529800400302     Document Type: Article

References (13)

1. Greco FA Chronic etoposide administration: overview of clinical experience. Cancer Treat Rev. (1993);19(suppl C):35-45.
2. Bargolie B., Smith L., Alexaman R. Effective treatment of advanced multiple myeloma refractory to alkylating agents. N Engl J Med. 1984; 310: 1353-1356.
3. Boddy AV, Yule SM, Wyllie R., Price L., Pearson Adj, Idle JR Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children. Cancer Res. 1993;53: 3758-3764.
4. Hardy EM, Williamson C., and Sewell GJ An evaluation of six infusion devices for the continuous infusion of cytotoxic drugs in ambulatory patients. J Oncol Pharm Practice. 1995; 1: 15-22.
5. Sewell GJ, Summerhayes M., Stanley A. Administration of chemotherapy. In: Allwood MA, Stanley A, Wright P, eds. The Cytotoxics Handbook. 3rd Ed. Oxford: Radcliffe Medical Press; 1997: 71-103.
6. Limit Test for Particulate Matter. London, Her Majesty's Stationary Office British Pharmacopoeia; 1993: A163.
7. Tidy Pjl. Stability of IV Azlocillin and Phenoperidine in a Freeze Thaw Procedure [thesis]. Bath, England: University of Bath; 1990: 35.
8. Particulate Contamination. London HMSO: British Pharmacopoeia 1993, Addendum 1994; 1993: A298.
9. Sewell GJ Mesna monograph. In: Allwood MA, Stanley A, Wright P, eds. The Cytotoxics Handbook. 3rd Ed. Oxford: Radcliffe Medical Press; 1997:368.
10. Brock N., Hilgard P., Phohl J., Ormstad K., Orrenius S. Pharmacokinetics, and mechanism of action of detoxifying low-molecular weight thiols. J Cancer Res Clin Oncol. 1984; 108: 87-97.
11. Compendium of Data Sheets, and Summaries of Product Characteristics 1998-1999. London: Datapharm Publications; 1998: 208.
12. Nguyen-Huu J., Bousquet O., Ihullou M. The compatibility of docetaxol infusion with intravenous administration and extension sets. J Oncol Pharm Practice. 1997; 3: 33-34.
13. Davis J. Etoposide phosphate: expands the horizon for etoposide. J Oncol Pharm Practice. 1997; 3: 13. page range.